Sio Gene Therapies Stock Jumps After FDA Granted Fast Track Designation for Investigational Gene Therapy in Patients with GM1 Gangliosidosis
Sio Gene Therapies Inc. (NASDAQ: SIOX) shares jumped more than 20% on Thursday after the clinical-stage company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AXO-AAV-GM1, its adeno-associated viral vector (AAV)9-based gene therapy...